NCT02752919View on ClinicalTrials.gov

Study of Galunisertib in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Healthy
Interventions
DRUG

Galunisertib

Administered orally

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician., Leeds

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT02752919 - Study of Galunisertib in Healthy Participants | Biotech Hunter | Biotech Hunter